Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
Apr 2010 - J. Gastroenterol.; 45(4):1435-5922 [PMID:19936602]
[Hiroishi K] [Eguchi J] [Baba T] [Shimazaki T] [Ishii S] [Hiraide A] [Sakaki M] [Doi H] [Uozumi S] [Omori R] [Matsumura T] [Yanagawa T] [Ito T] [Imawari M]